Beata Pajak-Tarnacka

Chief Scientific Officer

Waki Pharma

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Beata Pajak-Tarnacka serves as the Chief Scientific Officer at WPD Pharmaceuticals in Poland. Her research interests focus on cardiovascular risk assessment, anticancer agents, and the immune response related to glycolysis and its inhibitors. Recent publications include investigations into glioblastoma treatment options and the antiviral effects of 2-Deoxy-D-glucose. With a robust background in biochemistry and pharmacology, she contributes significantly to advancing therapeutic strategies against various diseases.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Wiktor Koźmiński

professor

University of Warsaw

POLAND

View details

Anna Zawadzka-Kazimierczuk

University of Warsaw

POLAND

View details

Pawel Szymanski

prof

Medical University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Beata Pajak-Tarnacka

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Assessing Cardiovascular Risk Among Polish Soldiers: Insights Using the POL SCORE Tool

Potent Biological Activity of Fluorinated Derivatives of 2-Deoxy-<span style="font-variant: small-caps">d</span>-Glucose in a Glioblastoma Model

The Impact of Glycolysis and Its Inhibitors on the Immune Response to Inflammation and Autoimmunity

X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution

WP1234—A Novel Anticancer Agent with Bifunctional Activity in a Glioblastoma Model

The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses

Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin

Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy

Holistic management of renal nephroblastoma in a juvenile dog with severe cachexia: A case report

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model

Collaborators (3)

Wiktor Koźmiński

Anna Zawadzka-Kazimierczuk

Pawel Szymanski

Make your next move.

Beata Pajak-Tarnacka

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Assessing Cardiovascular Risk Among Polish Soldiers: Insights Using the POL SCORE Tool

Potent Biological Activity of Fluorinated Derivatives of 2-Deoxy-<span style="font-variant: small-caps">d</span>-Glucose in a Glioblastoma Model

The Impact of Glycolysis and Its Inhibitors on the Immune Response to Inflammation and Autoimmunity

X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution

WP1234—A Novel Anticancer Agent with Bifunctional Activity in a Glioblastoma Model

The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses

Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin

Looking for the Holy Grail&mdash;Drug Candidates for Glioblastoma Multiforme Chemotherapy

Holistic management of renal nephroblastoma in a juvenile dog with severe cachexia: A case report

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model

Collaborators (3)

Wiktor Koźmiński

Anna Zawadzka-Kazimierczuk

Pawel Szymanski

Make your next move.

Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy